Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the
Lupin Q2FY23 results out: Net profit rises more than 100%
Categories
API
Divi’s Laboratories Ltd Q2 FY23 Earnings Conference Call Insights
https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global logistics scenario
Decoding India’s leading API development company – Dr Reddy’s Laboratories
About Company: Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company by global
Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked about the
Infographic: Divi’s Lab Q1 results out, Net profit rises 26%
On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at ₹702 crore as compared to ₹557